Phospholipase activity in Cryptococcus neoformans: A new virulence factor?

被引:123
作者
Chen, SCA
Muller, M
Zhou, JZ
Wright, LC
Sorrell, TC
机构
[1] Infectious Diseases/Microbiol. Ctr., Westmead Hospital, Westmead, NSW 2145, Hawkesbury Rd.
关键词
D O I
10.1093/infdis/175.2.414
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fifty isolates of Cryptococcus neoformans were examined for extracellular phospholipase production after inoculation onto egg yolk agar; 49 produced a pericolonial precipitate indicative of phospholipase activity. Phospholipase B (PLB), lysophospholipase, and lysophospholipase-transacylase activities were identified by radiometric analysis in supernatants from 4 clinical isolates. The ratio of colony diameter to colony plus precipitate on agar (Pz) correlated with PLB activity. Phospholipase production was similar in 12 environmental and 13 clinical isolates of C. neoformans var. gattii. Environmental strains of C. neoformans var. neoformans (n = 8) produced more phospholipase at 72 h than did 17 clinical isolates (mean Pt, 0.57 vs. 0.72; P < .01); however, Pz values were similar at 96 h. Quantitation of cryptococci in the lungs and brains of BALB/c mice inoculated intravenously with 4 strains expressing high, intermediate, or low phospholipase activity revealed a correlation between phospholipase activity and virulence. Phospholipases secreted by C. neoformans may be implicated in virulence.
引用
收藏
页码:414 / 420
页数:7
相关论文
共 27 条
  • [1] BARRETTBEE K, 1985, J GEN MICROBIOL, V131, P1217
  • [2] Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatus
    Birch, M
    Robson, G
    Law, D
    Denning, DW
    [J]. INFECTION AND IMMUNITY, 1996, 64 (03) : 751 - 755
  • [3] BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
  • [4] CRYPTOCOCCAL CAPSULAR POLYSACCHARIDE-INDUCED MODULATION OF MURINE IMMUNE-RESPONSES
    BREEN, JF
    LEE, IC
    VOGEL, FR
    FRIEDMAN, H
    [J]. INFECTION AND IMMUNITY, 1982, 36 (01) : 47 - 51
  • [5] BREUSKE CH, 1986, J CLIN MICROBIOL, V23, P631
  • [6] CHEN S, 1995, AUSTR SOC MICR ANN M, P16
  • [7] POLYSACCHARIDE ANTIGENS OF THE CAPSULE OF CRYPTOCOCCUS-NEOFORMANS
    CHERNIAK, R
    SUNDSTROM, JB
    [J]. INFECTION AND IMMUNITY, 1994, 62 (05) : 1507 - 1512
  • [8] INFECTIONS WITH CRYPTOCOCCUS-NEOFORMANS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME
    CHUCK, SL
    SANDE, MA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (12) : 794 - 799
  • [9] NATURAL HABITAT OF CRYPTOCOCCUS-NEOFORMANS VAR GATTII
    ELLIS, DH
    PFEIFFER, TJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (07) : 1642 - 1644
  • [10] DECREASED VIRULENCE IN STABLE, ACAPSULAR MUTANTS OF CRYPTOCOCCUS-NEOFORMANS
    FROMTLING, RA
    SHADOMY, HJ
    JACOBSON, ES
    [J]. MYCOPATHOLOGIA, 1982, 79 (01) : 23 - 29